Cargando…
Permitted Daily Exposure for Diisopropyl Ether as a Residual Solvent in Pharmaceuticals
Solvents can be used in the manufacture of medicinal products provided their residual levels in the final product comply with the acceptable limits based on safety data. At worldwide level, these limits are set by the “Guideline Q3C (R6) on impurities: guideline for residual solvents” issued by the...
Autores principales: | Romanelli, Luca, Evandri, Maria Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Toxicology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903142/ https://www.ncbi.nlm.nih.gov/pubmed/29686773 http://dx.doi.org/10.5487/TR.2018.34.2.111 |
Ejemplares similares
-
Draft Genome Sequence of Mycolicibacterium sp. Strain CH28, a Potential Degrader of Diisopropyl Ether, Isolated from Pharmaceutical Wastewater
por: Zsilinszky, Ingrid, et al.
Publicado: (2019) -
Diisopropylammonium nitrite
por: Wang, Ying-Chun, et al.
Publicado: (2012) -
Multiple responses optimization in the development of a headspace gas chromatography method for the determination of residual solvents in pharmaceuticals()
por: Teglia, Carla M., et al.
Publicado: (2015) -
Diisopropylammonium thiocyanate
por: Xu, Jie
Publicado: (2012) -
Diisopropylammonium methanesulfonate
por: Reiss, Guido J., et al.
Publicado: (2011)